Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Plenary Session 2: Targeting the Metabolic Basis of Cancer

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Plenary Session 2: Targeting the Metabolic Basis of Cancer
  •  
  • Permission not
    granted for presentation
  •  
  •  
The metabolic phase of the cell cycle
Eyal Gottlieb
Cancer Research UK, Beatson Institute, Glasgow, United Kingdom
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 3:15 PM-5:15 PM
Plenary Session 2: Targeting the Metabolic Basis of Cancer
The genetic basis of kidney cancer: A metabolic disease
W. Marston Linehan
National Cancer Inst., Bethesda, MD, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 3:15 PM-5:15 PM
Plenary Session 2: Targeting the Metabolic Basis of Cancer
Ras-induced macropinocytosis: Metabolic adaptation to signaling in the absence of adequate nutrients
Craig B. Thompson
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 3:15 PM-5:15 PM
Plenary Session 2: Targeting the Metabolic Basis of Cancer
  •  
  • Permission not
    granted for presentation
  •  
  •  
IDH mutations and tumorigenicity
Katharine E. Yen
Agios Pharmaceuticals, Cambridge, MA, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 3:15 PM-5:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4